Skip to main content

Table 4 Independent predictors of all-cause mortality

From: Combined value of left ventricular ejection fraction and the Model for End-Stage Liver Disease (MELD) score for predicting mortality in patients with acute coronary syndrome who were undergoing percutaneous coronary intervention

Variable Univariate Multivariate
HR 95% CI p-value HR 95% CI p-value
Age (per 1 year) 1.042 1.029–1.056 < 0.001 1.023 1.008–1.038 0.002
Male 0.663 0.486–0.904 0.009 0.944 0.666–1.354 0.774
Diabetes mellitus 1.780 1.327–2.387 < 0.001 1.384 1.004–1.907 0.047
Hipertension 1.480 1.103–1.986 0.009 0.999 0.719–1.390 0.997
Stroke history 2.602 1.617–4.189 < 0.001 1.954 1.193–3.200 0.008
History of CAD 1.370 1.013–1.852 0.011 1.113 0.804–1.542 0.518
Major bleeding 1.898 0.970–3.713 0.068 0.812 0.395–1.669 0.571
Multi-vessel disease 1.872 1.392–2.518 < 0.001 1.197 0.866–1.654 0.276
Killip class ≥2 5.545 3.981–7.722 < 0.001 4.149 2.907–5.922 < 0.001
LVEF (per 1% change) 0.957 0.945–0.969 < 0.001 0.972 0.958–0.986 < 0.001
Hemoglobin (per 1 mg/dl) 0.805 0.748–0.866 < 0.001 0.887 0.816–0.965 0.005
WBC (per 103/L) 1.081 1.043–1.121 < 0.001 1.063 1.024–1.103 0.001
B-blocker use at follow-up 0.489 0.351–0.682 < 0.001 0.638 0.444–0.917 0.015
ACE/ARB use at follow-up 0.452 0.331–0.619 < 0.001 0.989 0.668–1.464 0.956
TVR 0.490 0.266–0.902 0.022 0.765 0.410–1.4128 0.401
MELDa score (per 1 point) 1.291 1.222–1.364 < 0.001 1.116 1.069–1.164 < 0.001
  1. HR hazard ratio, CI confidence interval, LVEF left ventricular ejection fraction, MELD model for end-stage liver disease, WBC white blood cell, HDL-C high-density lipoprotein cholesterol, ACE-I/ARB angiotensin-converting enzyme inhibitors/ angiotensin-reseptor blocker, TVR target vessel revascularization
  2. aConsidered as continous variable